Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

PHASE3CompletedINTERVENTIONAL

Enrollment

935

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

February 8, 2021

Study Completion Date

February 8, 2021

Conditions

COVID-19

Interventions

DRUG

Nitazoxanide

Two nitazoxanide 300 mg tablets administered orally twice daily with food for 5 days

DRUG

Placebo

Two placebo tablets administered orally twice daily with food for 5 days

DIETARY_SUPPLEMENT

Vitamin Super B-Complex

Vitamin Super B-Complex administered orally twice daily to maintain the blind

Trial Locations (2)

RH Medical Urgent Care, The Bronx

Invesclinic US LLC, Fort Lauderdale

All Listed Sponsors

lead

Romark Laboratories L.C.

INDUSTRY

NCT04486313 - Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 | Biotech Hunter | Biotech Hunter